International Journal of General Medicine (Apr 2022)

Acute Kidney Injury among Hospital-Admitted COVID-19 Patients: A Study from Jordan

  • Oweis AO,
  • Alshelleh SA,
  • Hawasly L,
  • Alsabbagh G,
  • Alzoubi KH

Journal volume & issue
Vol. Volume 15
pp. 4475 – 4482

Abstract

Read online

Ashraf O Oweis,1 Sameeha A Alshelleh,2 Lubna Hawasly,3 Ghalia Alsabbagh,3 Karem H Alzoubi4,5 1Department of Internal Medicine, Nephrology Division, Jordan University of Science and Technology, Irbid, Jordan; 2Department of Internal Medicine, Nephrology Division, University of Jordan, Amman, Jordan; 3Department of Internal Medicine, Jordan University of Science and Technology, Irbid, Jordan; 4Department of Pharmacy Practice and Pharmacotherapeutics, University of Sharjah, Sharjah, United Arab Emirates; 5Department of Clinical Pharmacy, Jordan University of Science and Technology, Irbid, JordanCorrespondence: Ashraf O Oweis, Department of Internal Medicine, Nephrology Division, Jordan University of Science and Technology, Irbid, Jordan, Tel +962-79-145-5505, Email [email protected]: During the COVID-19 pandemic, many patients have been admitted to hospitals with severe respiratory disease and suffered complications. Acute kidney injury (AKI) is among the more dangerous complications contributing to morbidity and mortality among patients.Methods: This retrospective study focused on all hospital-admitted COVID-19 patients between September and December 2020. A total of 1,044 patients were enrolled. Patient demographics, medical records, and laboratory data were gathered. Patients were split into two groups: AKI and non-AKI. Comparisons comprised demographics, labs, ICU transfer, need for ventilation and oxygen therapy, medications, hospital stay, and deaths.Results: AKI incidence in the cohort was 25.3%, and a majority were stage 1 (53.3%). Among these, hemodialysis was started in 1.8%. Higher age (P< 0.001), diabetes mellitus (P=0.001), hypertension (P=0.001), ACEI/ARB use (P=0.008), erythrocyte-sedimentation rate (P=0.002), CRP (P< 0.0001), and ferritin (P=0.01) were predictors of AKI. Among all admitted COVID-19 patients, 30.2% died in hospital. Among those with AKI, 75.9% died in comparison to 24.1% of non-AKI patients (P< 0.001). Among COVID-19 patients admitted to the ICU, 80.5% died: 70.5% were from the AKI group and 29.5% from the non-AKI group (P< 0.001).Conclusion: High mortality and morbidity is associated with COVID-19 infection, and AKI is contributing significantly to the outcomes of hospitalized patients with the infection. Early recognition of and treatment for AKI will decrease mortality and hospitalization in patients with COVID-19.Keywords: acute kidney injury, COVID, mortality, dialysis

Keywords